Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1089886
Max Phase: Preclinical
Molecular Formula: C17H15BrI2N2O3
Molecular Weight: 629.03
Molecule Type: Small molecule
Associated Items:
ID: ALA1089886
Max Phase: Preclinical
Molecular Formula: C17H15BrI2N2O3
Molecular Weight: 629.03
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(CNC(=O)c1cc(Br)ccc1O)/N=C/c1cc(I)cc(I)c1O
Standard InChI: InChI=1S/C17H15BrI2N2O3/c1-9(21-8-10-4-12(19)6-14(20)16(10)24)7-22-17(25)13-5-11(18)2-3-15(13)23/h2-6,8-9,23-24H,7H2,1H3,(H,22,25)/b21-8+
Standard InChI Key: SDJKCUGKKXAMLC-ODCIPOBUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 629.03 | Molecular Weight (Monoisotopic): 627.8356 | AlogP: 4.31 | #Rotatable Bonds: 5 |
Polar Surface Area: 81.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.21 | CX Basic pKa: 4.29 | CX LogP: 5.88 | CX LogD: 5.41 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.34 | Np Likeness Score: -0.93 |
1. Cheng K, Zheng QZ, Hou J, Zhou Y, Liu CH, Zhao J, Zhu HL.. (2010) Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics., 18 (7): [PMID:20304657] [10.1016/j.bmc.2010.02.052] |
Source(1):